This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H13N8 Hemagglutinin (HA), C-His
Product Overview
BioVenic's Recombinant Influenza A H13N8 Hemagglutinin (HA), C-His is a recombinant protein expressed from Baculovirus-insect cell. Its predicted molecular weight is 58.5 kDa. The purity is>95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
Influenza A viruses (IAVs) present a significant risk to global health. One such subtype is H13N8. The hemagglutinin (HA) protein, an important glycoprotein of the influenza virus, is vital in the initial phases of viral infection.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.